Reference
Satoh M, et al. Effect of treatment with epoprostenol and endothelin receptor antagonists on the development of thyrotoxicosis in patients with pulmonary arterial hypertension. Endocrine Journal 64: 1173-1180, No. 12, Dec 2017. Available from: URL: http://doi.org/10.1507/endocrj.EJ17-0155 -Japan
Rights and permissions
About this article
Cite this article
Epoprostenol. Reactions Weekly 1697, 162 (2018). https://doi.org/10.1007/s40278-018-44718-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-44718-2